AstraBio

Founded on 2019, ASTRABIO is a high-tech company for industrialization of single molecule immunoassay, with fully independent intellectual property rights for the core technology. Adhering to the concept of Precise Detection For Human Health, Technical Innovation For Infinite Future, ASTRABIO has always been committed to the R&D and industrialization of the new generation of single-molecule immunoassay technology. AstraBio’s SMID technology empowering researchers to bring new discoveries in disease and treatment to the forefront with ultra-sensitive,high-throughput, fully automatic,cost-effective instruments and wide-ranging menu of assay kits.Our cutting-edge instruments have the ability to detect neurological biomarkers at ultra-low levels(fg/ml), which has the potential to transform the way brain injuries and diseases are diagnosed and enabling better understanding of the long-term effects and disease pathology with less invasive method.